PEPTINNOVATE
Peptinnovate Limited, is a U.K. drug development company developing a ‘first in class’ immune regulating therapy for inflammatory diseases.
PEPTINNOVATE
Industry:
Pharmaceutical Therapeutics
Founded:
2011-01-01
Address:
Stevenage, Herefordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.peptinnovate.com
Total Employee:
1+
Status:
Active
Contact:
0044-7703194341
Total Funding:
4.01 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS LiteSpeed
Current Advisors List
Board_member
Founder
Investors List
24 Haymarket
24 Haymarket investment in Venture Round - Peptinnovate
24 Haymarket
24 Haymarket investment in Venture Round - Peptinnovate
Fund Twenty8
Fund Twenty8 investment in Series A - Peptinnovate
NCL Technology Ventures
NCL Technology Ventures investment in Series A - Peptinnovate
Official Site Inspections
http://www.peptinnovate.com
- Host name: 172.80.78.26
- IP address: 172.80.78.26
- Location: Los Angeles United States
- Latitude: 34.0584
- Longitude: -118.278
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90017
More informations about "Peptinnovate"
Peptinnovate announces change of name to Immune Regulation
Nov 22, 2019 Peptinnovate Ltd (‘Peptinnovate’ or the ‘Company’, a biotechnology company developing novel immune modulators for immunological and inflammatory diseases, …See details»
Peptinnovate - Crunchbase Company Profile & Funding
Peptinnovate is a drug development company that develops immune regulating therapy for inflammatory diseases.See details»
Peptinnovate Ltd Company Profile | Management and Employees …
Peptinnovate Ltd Profile and History Peptinnovate is a drug development company developing a 'first in class' immune regulating therapy for asthma. Its products have the ability to …See details»
Peptinnovate announces change of name to Immune Regulation
Nov 28, 2018 Stevenage, UK, 22 November, 2018 - Peptinnovate Ltd (‘Peptinnovate’ or the ‘Company’, a biotechnology company developing novel immune modulators for immunological …See details»
Immune Regulation Ltd.. (11/22/18). "Press Release: Peptinnovate ...
Peptinnovate Ltd (‘Peptinnovate’ or the ‘Company’, a biotechnology company developing novel immune modulators for immunological and inflammatory diseases, announces that it has …See details»
Peptinnovate announces change of name to Immune Regulation ...
Peptinnovate announces change of name to Immune Regulation, strengthening of the Board and successful fundraise Stevenage, UK, 22 November, 2018 - Peptinnovate Ltd (‘Peptinnovate’ or …See details»
Peptinnovate Ltd: Contact Details and Business Profile - RocketReach
Peptinnovate Ltd is a drug development company engaged in research and development of innovative new therapies, targeting a range of immuno–inflammatory diseases.We believe that …See details»
Peptinnovate Ltd - Overview, News & Competitors | ZoomInfo.com
View Peptinnovate Ltd (www.peptinnovate.com) location in Hertfordshire, United Kingdom , revenue, industry and description. Find related and similar companies as well as employees …See details»
Immune Regulation (Group) - Life-Sciences-Europe.com
Nov 22, 2018 Immune Regulation Limited is a clinical stage biotech company, pioneering new technologies for regulating and resetting the immune system and developing novel first-in …See details»
Peptinnovate - Funding, Financials, Valuation & Investors
Peptinnovate is a drug development company that develops immune regulating therapy for inflammatory diseases.See details»
Peptinnovate - Products, Competitors, Financials, Employees ...
Peptinnovate is a drug development company that offers services in research and development of new therapies, targeting a range of immuno–inflammatory diseases. Use the CB Insights …See details»
Peptinnovate - Crunchbase
Peptinnovate is a drug development company that develops immune regulating therapy for inflammatory diseases.See details»
Peptinnovate - Tech Stack, Apps, Patents & Trademarks
Peptinnovate is a drug development company that develops immune regulating therapy for inflammatory diseases.See details»
Resetting the immune system to reduce asthma symptoms - Drug …
Nov 26, 2018 Stevenage, UK— Immune Regulation announced today positive results from a Phase 1 study of its lead compound PIN201104 (‘1104). Immune Regulation, formerly known …See details»
Immune Regulation announces positive results from Phase 1 …
Nov 26, 2019 Immune Regulation Ltd. (‘Immune Regulation’ or the ‘Company’, formerly known as Peptinnovate), a biopharmaceutical company developing “first in class” immune-resetting …See details»
A First-time-in-human, Randomised, Double-blind, Placebo …
Most Recent Events 26 Nov 2018 Results presented in an Immune Regulation Media Release. 22 Nov 2018 According to an Immune Regulation media release, Peptinnovate acquired Immune …See details»
PIN-201104 - Drug Targets, Indications, Patents - Synapse
PIN-201104: a Chaperonin stimulators Drug, Initially developed by Peptinnovate Ltd, Now, its global highest R&D status is Phase 2, Mechanism: Chaperonin stimulators, Therapeutic …See details»
Peptinnovate - Contacts, Employees, Board Members, Advisors
Peptinnovate is a drug development company that develops immune regulating therapy for inflammatory diseases.See details»
PEPTINNOVATE LTD innovation strategy - GoodIP
PEPTINNOVATE LTD has a total of 16 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2001. It filed its patents most often in United Kingdom, …See details»
Series A - Peptinnovate - 2017-06-17 - Crunchbase
Overview Organization Name Peptinnovate Announced Date Jun 17, 2017 Funding Type Series A Funding Stage Early Stage Venture Money Raised £2.7MSee details»